Find policies, billing codes, payers, states, and providers
CPT 33270: Subcutaneous Implantable Cardioverter-Defibrillator Insertion or Replacement
CPT code 33270 describes the surgical insertion or replacement of a permanent subcutaneous implantable cardioverter defibrillator (S-ICD) system and, when required, intraoperative testing and programming to confirm sensing and therapeutic function. This procedure is clinically significant nationwide because S-ICD systems provide a non-transvenous option for ventricular arrhythmia protection, affecting device selection, facility resource needs, and perioperative cardiac care pathways. Payers commonly involved in coverage include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise explanation of the clinical service represented by CPT code 33270, the typical settings where the service is delivered, and the stakeholders involved in payment and coverage. The publication provides benchmarking context, common billing considerations, and relevant policy updates that affect reimbursement and documentation practices. Clinical context covers indications for S-ICD use, intraoperative testing components such as defibrillation threshold evaluation and arrhythmia induction, and the role of programming in achieving effective therapy. Policy and billing sections summarize typical payer coverage approaches, documentation elements that support medical necessity, and practical coding relationships. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 33270 policy alerts
Get alerted when payer policies referencing 33270 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 33270 describes the insertion or replacement of a permanent subcutaneous implantable cardioverter defibrillator (S-ICD) system. The procedure includes placement of the device in a subcutaneous pocket and, when necessary, intraoperative evaluation of device performance through a defibrillation threshold evaluation, induction of arrhythmia, and assessment of sensing for arrhythmia termination. The provider also programs or reprograms sensing and therapeutic parameters to meet the patient's needs.
Service type: Surgical implantable cardiac device procedure
Typical site of service: Hospital operating room or ambulatory surgical center with cardiac electrophysiology capability